Photo detail

The outside of Scripps Research, which would gain surer financial footing if ozanimod is approved. Photo courtesy of Scripps

Stories this photo appears in:

Potential Blockbuster Drug Could Bring Windfall to Scripps

Scripps Research stands to gain a royalty windfall from a drug candidate that slows brain atrophy in patients with multiple sclerosis.

Tease photo